JPS5962591A - エブルナン−オキシム誘導体及びその製造方法、並びに該誘導体を含有する医薬 - Google Patents

エブルナン−オキシム誘導体及びその製造方法、並びに該誘導体を含有する医薬

Info

Publication number: JPS5962591A
Authority: JP; Japan
Prior art keywords: formula; racemic; oxime; ebrunan; optically active
Prior art date: 1982-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP58116245A

Other languages

English (en)

Japanese (ja)

Inventor

チヤバ・サンタイ

ラヨス・サボ

ジエルギ・カラウス

ヤノス・サピ

エバ・パロシ

ベラ・キツス

マリア・ザエル

エゴン・カルパテイ

ラスロ・スポルニイ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Richter Gedeon Nyrt

Richter Gedeon Vegyeszeti Gyar Nyrt

Original Assignee

Richter Gedeon Nyrt

Richter Gedeon Vegyeszeti Gyar RT

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-06-30

Filing date

1983-06-29

Publication date

1984-04-10

1983-06-29 Application filed by Richter Gedeon Nyrt, Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Nyrt

1984-04-10 Publication of JPS5962591A publication Critical patent/JPS5962591A/ja

Status Pending legal-status Critical Current

Links

239000003814 drug Substances 0.000 title claims description 14
238000000034 method Methods 0.000 title claims description 6
239000002253 acid Substances 0.000 claims description 14
150000003839 salts Chemical class 0.000 claims description 9
125000004432 carbon atom Chemical group C* 0.000 claims description 8
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
125000000217 alkyl group Chemical group 0.000 claims description 7
239000007787 solid Substances 0.000 claims description 6
239000007788 liquid Substances 0.000 claims description 5
239000000203 mixture Substances 0.000 claims description 5
239000004480 active ingredient Substances 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
239000000654 additive Substances 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims description 2
238000002156 mixing Methods 0.000 claims description 2
150000002923 oximes Chemical class 0.000 claims description 2
239000000546 pharmaceutical excipient Substances 0.000 claims description 2
WYJAPUKIYAZSEM-MOPGFXCFSA-N Eburnamonine Chemical class C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)CC(=O)N5C2=C1 WYJAPUKIYAZSEM-MOPGFXCFSA-N 0.000 claims 1
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 1
230000000996 additive effect Effects 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
150000001875 compounds Chemical class 0.000 description 16
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
239000000243 solution Substances 0.000 description 9
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
239000000047 product Substances 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
239000011541 reaction mixture Substances 0.000 description 5
239000007858 starting material Substances 0.000 description 5
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
-1 alkali metal amide Chemical class 0.000 description 4
229940079593 drug Drugs 0.000 description 4
229910052700 potassium Inorganic materials 0.000 description 4
239000011591 potassium Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
235000019270 ammonium chloride Nutrition 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
238000006146 oximation reaction Methods 0.000 description 3
239000002904 solvent Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
229960004050 aminobenzoic acid Drugs 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
239000012467 final product Substances 0.000 description 2
239000007903 gelatin capsule Substances 0.000 description 2
235000011167 hydrochloric acid Nutrition 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
239000003208 petroleum Substances 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 2
239000012414 tert-butyl nitrite Substances 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
238000005160 1H NMR spectroscopy Methods 0.000 description 1
JXCNBASKFCBVAN-UHFFFAOYSA-N 2-methylbutan-2-yl nitrite Chemical compound CCC(C)(C)ON=O JXCNBASKFCBVAN-UHFFFAOYSA-N 0.000 description 1
WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
102100024479 Cell division cycle-associated protein 3 Human genes 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
239000004380 Cholic acid Substances 0.000 description 1
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
229920000832 Cutin Polymers 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
239000004278 EU approved seasoning Substances 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
241000489045 Helosis Species 0.000 description 1
101000980907 Homo sapiens Cell division cycle-associated protein 3 Proteins 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
239000003082 abrasive agent Substances 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229960004909 aminosalicylic acid Drugs 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
230000000141 anti-hypoxic effect Effects 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000002585 base Substances 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
229960004365 benzoic acid Drugs 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000013522 chelant Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
235000019416 cholic acid Nutrition 0.000 description 1
229960002471 cholic acid Drugs 0.000 description 1
235000013985 cinnamic acid Nutrition 0.000 description 1
229930016911 cinnamic acid Natural products 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000013078 crystal Substances 0.000 description 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000001914 filtration Methods 0.000 description 1
235000011194 food seasoning agent Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
241000411851 herbal medicine Species 0.000 description 1
229910000042 hydrogen bromide Inorganic materials 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000008101 lactose Substances 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
150000002736 metal compounds Chemical class 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000003495 polar organic solvent Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
WYJAPUKIYAZSEM-UHFFFAOYSA-N rac-Eburnamonin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(=O)N5C2=C1 WYJAPUKIYAZSEM-UHFFFAOYSA-N 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
238000007873 sieving Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
229950000244 sulfanilic acid Drugs 0.000 description 1
150000003460 sulfonic acids Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
229960002922 vinburnine Drugs 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

JP58116245A 1982-06-30 1983-06-29 エブルナン−オキシム誘導体及びその製造方法、並びに該誘導体を含有する医薬 Pending JPS5962591A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU2131/82		1982-06-30
HU822131A HU190400B (en)	1982-06-30	1982-06-30	Process for preparing new eburnan-oxime derivatives

Publications (1)

Publication Number	Publication Date
JPS5962591A true JPS5962591A (ja)	1984-04-10

Family

ID=10957920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP58116245A Pending JPS5962591A (ja)	1982-06-30	1983-06-29	エブルナン−オキシム誘導体及びその製造方法、並びに該誘導体を含有する医薬

Country Status (18)

Country	Link
JP (1)	JPS5962591A (de)
AT (1)	AT385990B (de)
AU (1)	AU554196B2 (de)
BE (1)	BE897148A (de)
CA (1)	CA1199919A (de)
CH (1)	CH656881A5 (de)
DE (1)	DE3323606A1 (de)
DK (1)	DK300583A (de)
ES (1)	ES523695A0 (de)
FR (1)	FR2529551B1 (de)
GB (1)	GB2124215B (de)
GR (1)	GR77525B (de)
HU (1)	HU190400B (de)
IL (1)	IL69107A (de)
NL (1)	NL8302298A (de)
NZ (1)	NZ204754A (de)
PT (1)	PT76951B (de)
SE (1)	SE457641B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU191403B (en) *	1984-04-02	1987-02-27	Richter Gedeon Vegyeszeti Gyar Rt,Hu	Process for preparing new, raceme and optically active 14-hydroxyimino-eburnane
US4735943A (en) *	1984-06-29	1988-04-05	Sanwa Kagaku Kenkyusho Co., Ltd.	Eburnamonine oxime derivatives, salts thereof, and pharmaceutical agents containing the same
USD1069018S1 (en)	2021-10-25	2025-04-01	Maxim Defense Industries, LLC	Firearm suppressor core
US12449219B2 (en)	2021-08-30	2025-10-21	Maxim Defense Industries, LLC	Firearm suppressor and self-torquing feature
USD1035816S1 (en)	2022-01-14	2024-07-16	Maxim Defense Industries, LLC	Combined firearm suppressor core, mount body, tube, and spring
USD1036611S1 (en)	2022-01-14	2024-07-23	Maxim Defense Industries, LLC	Combined firearm suppressor core, mount body, and tube
USD1057070S1 (en) *	2022-01-14	2025-01-07	Maxim Defense Industries, LLC	Firearm suppressor core

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2085630A1 (en) *	1970-04-07	1971-12-31	Le Men Georges	Vincamone compsn - having vasodilator ganglioplegic and antihistamine activity
FR2206090A1 (en) *	1972-11-16	1974-06-07	Omnium Chimique Sa	Homovincamone-contg. medicaments - with vasodilating, spasmolytic anti-arrhythmic and anti-ischaemic properties
US4315011A (en) *	1978-07-12	1982-02-09	Richter Gedeon Vegyeszeti Gyar Rt.	1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
FR2454808A1 (fr) *	1979-04-26	1980-11-21	Roussel Uclaf	Application a titre de medicaments d'oximes derivees du e-homo eburnane, oximes derivees du e-homo eburnane et preparation

1982
- 1982-06-30 HU HU822131A patent/HU190400B/hu not_active IP Right Cessation
1983
- 1983-06-28 BE BE1/10823A patent/BE897148A/fr not_active IP Right Cessation
- 1983-06-28 CH CH3529/83A patent/CH656881A5/de not_active IP Right Cessation
- 1983-06-29 PT PT76951A patent/PT76951B/pt unknown
- 1983-06-29 SE SE8303719A patent/SE457641B/sv not_active IP Right Cessation
- 1983-06-29 DK DK300583A patent/DK300583A/da not_active Application Discontinuation
- 1983-06-29 GB GB08317612A patent/GB2124215B/en not_active Expired
- 1983-06-29 NL NL8302298A patent/NL8302298A/nl not_active Application Discontinuation
- 1983-06-29 JP JP58116245A patent/JPS5962591A/ja active Pending
- 1983-06-29 CA CA000431474A patent/CA1199919A/en not_active Expired
- 1983-06-29 ES ES523695A patent/ES523695A0/es active Granted
- 1983-06-29 GR GR71804A patent/GR77525B/el unknown
- 1983-06-29 AU AU16396/83A patent/AU554196B2/en not_active Ceased
- 1983-06-29 AT AT0239083A patent/AT385990B/de not_active IP Right Cessation
- 1983-06-29 NZ NZ204754A patent/NZ204754A/en unknown
- 1983-06-29 IL IL69107A patent/IL69107A/xx unknown
- 1983-06-29 FR FR8310734A patent/FR2529551B1/fr not_active Expired
- 1983-06-30 DE DE19833323606 patent/DE3323606A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
GB2124215A (en)	1984-02-15
AT385990B (de)	1988-06-10
HU190400B (en)	1986-08-28
ES8500619A1 (es)	1984-11-01
GR77525B (de)	1984-09-24
ES523695A0 (es)	1984-11-01
GB8317612D0 (en)	1983-08-03
DE3323606A1 (de)	1984-01-12
NL8302298A (nl)	1984-01-16
DK300583A (da)	1983-12-31
SE457641B (sv)	1989-01-16
CA1199919A (en)	1986-01-28
CH656881A5 (de)	1986-07-31
IL69107A (en)	1986-03-31
SE8303719L (sv)	1983-12-31
FR2529551A1 (fr)	1984-01-06
PT76951A (en)	1983-07-01
PT76951B (en)	1986-01-24
IL69107A0 (en)	1983-10-31
ATA239083A (de)	1987-11-15
NZ204754A (en)	1985-11-08
GB2124215B (en)	1985-08-29
BE897148A (fr)	1983-12-28
FR2529551B1 (fr)	1985-10-18
DK300583D0 (da)	1983-06-29
AU1639683A (en)	1984-01-05
AU554196B2 (en)	1986-08-14
SE8303719D0 (sv)	1983-06-29

Publication	Publication Date	Title
GB2126226A (en)	1984-03-21	Pyridine derivatives
DE3783751T2 (de)	1993-05-13	Glyzirrhetinsaeure-derivate und ihre anwendung.
DE2166752A1 (de)	1975-06-26	Pyridazinderivate
HU190400B (en)	1986-08-28	Process for preparing new eburnan-oxime derivatives
JPH0142952B2 (de)	1989-09-18
DE60103752T2 (de)	2005-07-14	Verfahren zur herstellung von pyrazolopyridinderivaten
US4549020A (en)	1985-10-22	Eburnane oxime ethers
US5708164A (en)	1998-01-13	Cephalostatin analogues
US2566336A (en)	1951-09-04	Preparation of keto-amine salts in the steroid series and products
US3084161A (en)	1963-04-02	New 3-methylsulphinyl phenothiazine derivatives
US4355166A (en)	1982-10-19	Quinuclidinic ester and derivatives of phenoxycarboxylic acids
JPS60208963A (ja)	1985-10-21	ジアミノピリジン誘導体の製造方法
EP0012801A1 (de)	1980-07-09	2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel
NZ204757A (en)	1985-08-16	Eburnane derivatives and pharmaceutical compositions
US2966494A (en)	1960-12-27	New pyridine compounds
US3479376A (en)	1969-11-18	Process for the preparation of 17-substituted - 13 - alkylgona - 1,3,5(10),6,8-pentaenes
JPS6322577A (ja)	1988-01-30	ｔ−ブチルエルゴリン誘導体
IE44449B1 (en)	1981-12-02	11-methylene-6-piperazinyl-morphanthridine derivatives
JPS60197663A (ja)	1985-10-07	スルフアモイルアミジン誘導体及びその製法
JPH0436285A (ja)	1992-02-06	シネルギスチンの製造方法
JPS5862161A (ja)	1983-04-13	アミノメチル−１ｈ−インド−ル−４−メタノ−ルの新誘導体及びそれらの塩、これらの製造方法及び中間体、これらの薬剤としての使用並びにこれを含有する組成物
JPS5910358B2 (ja)	1984-03-08	新規エルゴリン誘導体
JP2008528656A (ja)	2008-07-31	四環性テルペン系化合物、その製造方法、薬剤としてのそれらの使用、およびこれらを含む医薬化合物
HU183985B (en)	1984-06-28	Process for producing new oktahydro-indolo-square bracket-2,3-a-square bracket closed-quinolizin-ester derivatives
HU190598B (en)	1986-09-29	Process for preparing new octahydro-indolo/2,3-a/quinolizine derivatives